Dolasetron to prevent nausea from chemo in kids with leukemia
Part of Cancer, Digestive system clinical trials.
This trial tests if a medicine called dolasetron can prevent chemotherapy-related nausea and vomiting in children with acute lymphoblastic leukemia (ALL). It may help kids feel better during their first round of treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 and 17 years old
- You have been diagnosed with acute lymphoblastic leukemia (ALL)
- You are about to start your first chemotherapy treatment for ALL
- You are in reasonably good health otherwise (ECOG score 0-2)
- You are expected to live at least 3 more months
- You or your guardian can fill out a daily diary
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This trial tests a new injection, HSK21542, to see if it can prevent nausea and vomiting caused by strong chemotherapy drugs. It may help people who have never had chemo before.
This trial compares two forms of ondansetron (a nausea medicine) — a dissolving film you put in the mouth versus a needle injection — to see which works better in preventing nausea and vomiting caused by chemotherapy in children with solid tumors.
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
This trial tests a treatment plan for children with newly diagnosed acute lymphoblastic leukemia (ALL) that is considered standard-risk. It aims to see if the treatment is effective and safe.
This trial tests a new form of megestrol acetate to prevent nausea and vomiting caused by chemotherapy in people with advanced stomach cancer who haven't had chemo before. It's for those starting a specific chemo combo that includes a PD-1 inhibitor and CAPOX.
Hear when a new Chemotherapy-induced Nausea and Vomiting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.